查看购物车
  • Traditional Chinese
  • English
  • Japanese
  • Korean
封面
市场调查报告书
商品编码
1683376

全球先进伤口护理设备市场 - 2025 年至 2033 年

Global Advanced Wound Care Devices Market - 2025-2033
出版日期: | 出版商: DataM Intelligence | 英文 176 Pages | 商品交期: 最快1-2个工作天内

价格

※ 本网页内容可能与最新版本有所差异。详细情况请与我们联繫。

简介目录

2024 年全球先进伤口护理设备市场规模达到 38 亿美元，预计到 2033 年将达到 52.2 亿美元，在 2025-2033 年预测期间的复合年增长率为 4.3%。

先进伤口护理设备市场是医疗保健行业的一个专业领域，专注于旨在促进伤口更快癒合、预防感染和改善患者预后的医疗设备和技术。这些装置超越了传统的伤口敷料，采用了在细胞层面优化伤口癒合的创新机制。先进伤口护理设备的类型包括负压伤口治疗（NPWT）、高压氧治疗（HBOT）设备、电刺激设备和压力释放设备。

NPWT 使用真空系统去除多余的液体并促进癒合。 HBOT设备增强伤口的氧气供应，促进细胞修復和再生。电刺激装置使用轻微的电脉衝来刺激细胞活动并增加血流量。压力释放装置有助于重新分配体重并降低卧床病患压疮的风险。

市场动态：

驱动因素与约束因素

不断进步的技术

技术进步是先进伤口护理设备市场的重要动力，为伤口癒合提供更有效率、更有效和创新的解决方案。随着伤口护理技术的发展，它们可以改善患者的治疗效果、缩短癒合时间、并提供更好的感染控制。

NPWT 设备的最新改进，例如更小、更便携的系统，提高了其可用性和有效性。现代 NPWT 系统提供更高程度的吸力控制，能够更有针对性地治疗伤口区域，促进更快的组织修復并减少伤口感染和裂开等併发症。 Smith & Nephew 和 3M 等公司推出了更用户友好且适合家庭护理环境的创新 NPWT 解决方案。

推动该市场成长的行业产品发布和审批的关键参与者。例如，2023 年 6 月，NovaBone Products 的 Wound Matrix 获得了 FDA 510(k) 批准，Wound Matrix 是一种结合胶原蛋白和 45S5 生物活性玻璃的新型伤口护理设备。本产品专为治疗各种伤口类型而设计，包括部分和全层伤口、溃疡（压力性、静脉性、糖尿病性和慢性血管性）以及手术、创伤和引流伤口。所有这些因素都要求全球先进的伤口护理设备市场。

缺乏熟练的医疗保健提供者

熟练医疗保健提供者的短缺是全球先进伤口护理设备市场成长的主要障碍。儘管伤口护理技术取得了重大进步，但这些设备的成功应用很大程度上取决于护理师、医生和伤口护理专家的专业知识。

许多先进的伤口护理设备，例如负压伤口治疗（NPWT）、电刺激设备或生物治疗，都需要专门的培训才能有效操作。如果没有足够的专业知识，这些技术可能无法充分发挥其潜力，从而降低其有效性并导致患者治疗效果不佳。训练不足或对设备不熟悉通常会导致使用不当。因此，上述因素可能会限制全球先进伤口护理设备市场的潜在成长。

目录

第一章：市场介绍和范围

  • 报告目标
  • 报告范围和定义
  • 报告范围

第 2 章：高阶主管见解与关键要点

  • 市场亮点和战略要点
  • 主要趋势和未来预测
  • 按产品类型分类的片段
  • 伤口类型片段
  • 材料片段
  • 最终用户的程式码片段
  • 按地区分类的片段

第 3 章：动态

  • 影响因素
    • 驱动程式
      • 技术进步
      • 慢性伤口盛行率上升
    • 限制
      • 缺乏熟练的医疗保健提供者
      • 缺乏对新兴市场的认知
    • 机会
      • 转向个人化治疗
    • 影响分析

第四章：战略洞察与产业展望

  • 市场领导者和先驱者
    • 新兴先锋和杰出参与者
    • 拥有最大销售品牌的成熟领导者
    • 拥有成熟产品的市场领导者
  • CXO 观点
  • 最新进展与突破
  • 案例研究/正在进行的研究
  • 监管和报销情况
    • 北美洲
    • 欧洲
    • 亚太地区
    • 拉丁美洲
    • 中东和非洲
  • 波特五力分析
  • 供应链分析
  • 专利分析
  • SWOT 分析
  • 未满足的需求和差距
  • 市场进入和扩张的推荐策略
  • 情境分析：最佳情况、基本情况和最坏情况预测
  • 定价分析和价格动态
  • 关键意见领袖

第 5 章：先进伤口护理设备市场（依产品类型）

  • 负压伤口治疗
  • 电疗
  • 生物光子疗法
  • 其他的

第 6 章：先进伤口护理设备市场（按伤口类型）

  • 皮肤溃疡
  • 手术伤口
  • 烧伤
  • 糖尿病足溃疡
  • 压疮
  • 手术伤口
  • 术后伤口
  • 其他的

第 7 章：进阶伤口护理设备市场（按最终用户划分）

  • 医院
  • 专科诊所
  • 家庭医疗保健
  • 其他的

第 8 章：先进伤口护理设备市场，按区域市场分析和成长机会

  • 北美洲
    • 我们
    • 加拿大
  • 欧洲
    • 德国
    • 英国
    • 法国
    • 西班牙
    • 义大利
    • 欧洲其他地区
  • 拉丁美洲
    • 墨西哥
    • 巴西
    • 阿根廷
    • 拉丁美洲其他地区
  • 亚太
    • 中国
    • 印度
    • 日本
    • 韩国
    • 亚太其他地区
  • 中东和非洲

第九章：竞争格局与市场定位

  • 竞争概况和主要市场参与者
  • 市占率分析与定位矩阵
  • 策略伙伴关係、併购
  • 产品组合和创新的关键发展
  • 公司基准化分析

第十章：公司简介

  • Smith+Nephew.
    • 公司概况
    • 产品组合
      • 产品描述
      • 产品关键绩效指标 (KPI)
      • 历史和预测产品销售量
      • 产品销售量
    • 财务概览
      • 公司收入
      • 地区收入份额
      • 收入预测
    • 主要进展
      • 合併与收购
      • 关键产品开发活动
      • 监管部门批准等
    • SWOT 分析
  • Gilero
  • Pensar Medical
  • Nexa Medical Limited
  • Solventum
  • Medela
  • Alleva Medical Ltd.
  • 3M
  • Talley Group Ltd
  • DeRoyal Industries, Inc.

第 11 章：假设与研究方法

  • 资料收集方法
  • 数据三角测量
  • 预测技术
  • 数据验证和确认

第 12 章：附录

简介目录
Product Code: MD9310

The global advanced wound care devices market reached US$ 3.80 billion in 2024 and is expected to reach US$ 5.22 billion by 2033, growing at a CAGR of 4.3 % during the forecast period of 2025-2033.

The advanced wound care devices market is a specialized segment of the healthcare industry that focuses on medical devices and technologies designed to promote faster wound healing, prevent infections and enhance patient outcomes. These devices go beyond traditional wound dressings by incorporating innovative mechanisms that optimize wound healing at a cellular level. Types of advanced wound care devices include negative pressure wound therapy (NPWT), hyperbaric oxygen therapy (HBOT) devices, electrical stimulation devices and pressure relief devices.

NPWT uses a vacuum system to remove excess fluid and promote healing. HBOT devices enhance oxygen supply to wounds, boosting cell repair and regeneration. Electrical Stimulation Devices use mild electrical impulses to stimulate cell activity and increase blood flow. Pressure relief devices help redistribute weight and reduce the risk of pressure ulcers for bedridden patients.

Market Dynamics: Drivers & Restraints

Rising Technological Advancements

Technological advancements are a significant driver in the advanced wound care devices market, facilitating more efficient, effective and innovative solutions for wound healing. As wound care technologies evolve, they offer improved patient outcomes, faster healing times and better infection control.

Recent improvements in NPWT devices, such as smaller, more portable systems, have increased their usability and effectiveness. Modern NPWT systems provide a higher degree of suction control, enabling more targeted treatment of wound areas, which promotes faster tissue repair and reduces complications like wound infection and dehiscence. Companies like Smith & Nephew and 3M have introduced innovative NPWT solutions that are more user-friendly and suitable for home care settings.

Key players in the industry's product launches and approvals that would drive this market growth. For instance, in June 2023, NovaBone Products received FDA 510(k) clearance for its Wound Matrix, a novel wound care device that combines collagen and 45S5 bioactive glass. This product is designed for managing various wound types, including partial and full-thickness wounds, ulcers (pressure, venous, diabetic and chronic vascular), as well as surgical, trauma and draining wounds. All these factors demand the global advanced wound care devices market.

Shortage of Skilled Healthcare Providers

The shortage of skilled healthcare providers is a major barrier to the growth of the global advanced wound care devices market. Despite significant advancements in wound care technology, the successful application of these devices largely depends on the expertise of nurses, physicians and wound care specialists.

Many advanced wound care devices, such as negative pressure wound therapy (NPWT), electrical stimulation devices, or biological treatments, require specialized training to operate effectively. Without sufficient expertise, these technologies may not be used to their full potential, which can reduce their effectiveness and lead to suboptimal patient outcomes. Inadequate training or unfamiliarity with the devices often results in improper application. Thus, the above factors could be limiting the global advanced wound care devices market's potential growth.

Segment Analysis

The global advanced wound care devices market is segmented based on product type, wound type, end-user and region.

Product Type:

The negative pressure wound therapy segment in product type is expected to dominate the global advanced wound care devices market

Negative pressure wound therapy (NPWT) systems are FDA Class II medical devices designed to promote wound healing by applying sub-atmospheric pressure to a wound site. These systems typically include a vacuum pump, drainage tubing and a wound dressing set, which work together to remove excess fluids such as wound exudate, irrigation fluids, bodily fluids, or infectious material.

NPWT devices generate suction using either an external power source or a battery-operated vacuum system, which helps create a controlled environment for faster wound healing, reduced swelling and improved tissue regeneration. Major players in the industry innovate product launches that would propel this segment's growth in the market.

For instance, in January 2022, Smith+Nephew's introduced PICO 7 and PICO 14 negative pressure wound therapy (sNPWT) Systems were the first to be indicated for reducing both deep and superficial incisional surgical site infections (SSIs) and dehiscence. These systems use negative pressure wound therapy (NPWT), which applies suction to a wound to remove excess fluid, promote healing, and reduce infection risks. These factors have solidified the segment's position in the global advanced wound care devices market.

Geographical Analysis

North America is expected to hold a significant position in the global advanced wound care devices market

The increasing rates of diabetes, vascular diseases, and other chronic conditions have led to a higher incidence of chronic wounds, such as diabetic foot ulcers, pressure ulcers and venous leg ulcers. This has significantly boosted the demand for advanced wound care devices designed to manage and treat these complex wounds.

North America's aging population is another crucial driver. Older individuals are more susceptible to developing chronic wounds due to conditions like poor circulation, immobility and other age-related issues. As the number of elderly people rises, the need for advanced wound care solutions continues to increase.

Innovations in wound care devices, such as negative pressure wound therapy (NPWT) systems, electrical stimulation devices and biologically active dressings, are improving the speed and efficiency of wound healing. These advancements are leading to better outcomes for patients and are driving the adoption of these devices in both clinical and home settings.

Additionally, in this region, a major of key players' presence, well-advanced healthcare infrastructure, product launches and approvals would drive this market growth. For instance, in March 2023, Vaporox, a U.S.-based medical device company, secured FDA clearance for its next-generation wound care device, the VHT-200. This system is designed to treat chronic wounds, particularly those that do not respond to conventional treatments, such as diabetic foot ulcers. The VHT-200 utilizes vaporous hyperoxia therapy (VHT), which combines ultrasonic mist and concentrated oxygen to accelerate wound healing. Thus, the above factors are consolidating the region's position as a dominant force in the global advanced wound care devices market.

Competitive Landscape

The major global players in the advanced wound care devices market include Smith+Nephew, Gilero, Pensar Medical, Nexa Medical Limited, Solventum, Medela, Alleva Medical Ltd., 3M, Talley Group Ltd and DeRoyal Industries, Inc., among others.

Key Developments

  • In August 2024, Sky Medical Technology announced that its geko device is now available on India's Government e-Marketplace (GeM) procurement portal, enabling government hospitals to easily purchase the device for medical use. The Geko device is a wearable neuromuscular electrostimulation (NMES) device designed to improve blood circulation, prevent venous thromboembolism (VTE) (life-threatening blood clots), reduce post-surgical swelling (edema) in orthopedic patients, and support the healing of chronic wounds such as leg ulcers.

Why Purchase the Report?

  • Pipeline & Innovations: Reviews ongoing clinical trials and product pipelines and forecasts upcoming advancements in medical devices and pharmaceuticals.
  • Product Performance & Market Positioning: Analyzed product performance, market positioning, and growth potential to optimize strategies.
  • Real-World Evidence: Integrates patient feedback and data into product development for improved outcomes.
  • Physician Preferences & Health System Impact: Examines healthcare provider behaviors and the impact of health system mergers on adoption strategies.
  • Market Updates & Industry Changes: This covers recent regulatory changes, new policies, and emerging technologies.
  • Competitive Strategies: Analyze competitor strategies, market share, and emerging players.
  • Pricing & Market Access: Reviews pricing models, reimbursement trends, and market access strategies.
  • Market Entry & Expansion: Identifies optimal strategies for entering new markets and partnerships.
  • Regional Growth & Investment: Highlights high-growth regions and investment opportunities.
  • Supply Chain Optimization: Assesses supply chain risks and distribution strategies for efficient product delivery.
  • Sustainability & Regulatory Impact: Focuses on eco-friendly practices and evolving regulations in healthcare.
  • Post-market Surveillance: Uses post-market data to enhance product safety and access.
  • Pharmacoeconomics & Value-Based Pricing: Analyzes the shift to value-based pricing and data-driven decision-making in R&D.

The global advanced wound care devices market report delivers a detailed analysis with 60+ key tables, more than 50 visually impactful figures, and 176 pages of expert insights, providing a complete view of the market landscape.

Target Audience 2024

  • Manufacturers: Pharmaceutical, Medical Device, Biotech Companies, Contract Manufacturers, Distributors, Hospitals.
  • Regulatory & Policy: Compliance Officers, Government, Health Economists, Market Access Specialists.
  • Technology & Innovation: AI/Robotics Providers, R&D Professionals, Clinical Trial Managers, Pharmacovigilance Experts.
  • Investors: Healthcare Investors, Venture Fund Investors, Pharma Marketing & Sales.
  • Consulting & Advisory: Healthcare Consultants, Industry Associations, Analysts.
  • Supply Chain: Distribution and Supply Chain Managers.
  • Consumers & Advocacy: Patients, Advocacy Groups, Insurance Companies.
  • Academic & Research: Academic Institutions.

Table of Contents

1. Market Introduction and Scope

  • 1.1. Objectives of the Report
  • 1.2. Report Coverage & Definitions
  • 1.3. Report Scope

2. Executive Insights and Key Takeaways

  • 2.1. Market Highlights and Strategic Takeaways
  • 2.2. Key Trends and Future Projections
  • 2.3. Snippet by Product Type
  • 2.4. Snippet by Wound Type
  • 2.5. Snippet by Material
  • 2.6. Snippet by End-User
  • 2.7. Snippet by Region

3. Dynamics

  • 3.1. Impacting Factors
    • 3.1.1. Drivers
      • 3.1.1.1. Technological Advancements
      • 3.1.1.2. Rising Prevalence of Chronic Wounds
    • 3.1.2. Restraints
      • 3.1.2.1. Shortage of Skilled Healthcare Providers
      • 3.1.2.2. Lack of Awareness in Emerging Markets
    • 3.1.3. Opportunity
      • 3.1.3.1. Shift Toward Personalized Treatment
    • 3.1.4. Impact Analysis

4. Strategic Insights and Industry Outlook

  • 4.1. Market Leaders and Pioneers
    • 4.1.1. Emerging Pioneers and Prominent Players
    • 4.1.2. Established leaders with largest selling Brand
    • 4.1.3. Market leaders with established Product
  • 4.2. CXO Perspectives
  • 4.3. Latest Developments and Breakthroughs
  • 4.4. Case Studies/Ongoing Research
  • 4.5. Regulatory and Reimbursement Landscape
    • 4.5.1. North America
    • 4.5.2. Europe
    • 4.5.3. Asia Pacific
    • 4.5.4. Latin America
    • 4.5.5. Middle East & Africa
  • 4.6. Porter's Five Forces Analysis
  • 4.7. Supply Chain Analysis
  • 4.8. Patent Analysis
  • 4.9. SWOT Analysis
  • 4.10. Unmet Needs and Gaps
  • 4.11. Recommended Strategies for Market Entry and Expansion
  • 4.12. Scenario Analysis: Best-Case, Base-Case, and Worst-Case Forecasts
  • 4.13. Pricing Analysis and Price Dynamics
  • 4.14. Key Opinion Leaders

5. Advanced Wound Care Devices Market, By Product Type

  • 5.1. Introduction
    • 5.1.1. Analysis and Y-o-Y Growth Analysis (%), By Product Type
    • 5.1.2. Market Attractiveness Index By Product Type
  • 5.2. Negative Pressure Wound Therapy*
    • 5.2.1. Introduction
    • 5.2.2. Market Size Analysis and Y-o-Y Growth Analysis (%)
  • 5.3. Electrotherapy
  • 5.4. Biophotonic Therapy
  • 5.5. Others

6. Advanced Wound Care Devices Market, By Wound Type

  • 6.1. Introduction
    • 6.1.1. Market Size Analysis and Y-o-Y Growth Analysis (%), By Wound Type
    • 6.1.2. Market Attractiveness Index By Wound Type
  • 6.2. Skin Ulcers*
    • 6.2.1. Introduction
    • 6.2.2. Market Size Analysis and Y-o-Y Growth Analysis (%)
  • 6.3. Surgical Wounds
  • 6.4. Burn Wounds
  • 6.5. Diabetic Foot Ulcers
  • 6.6. Pressure Ulcers
  • 6.7. Surgical Wounds
  • 6.8. Post-Operative Wounds
  • 6.9. Others

7. Advanced Wound Care Devices Market, By End-User

  • 7.1. Introduction
    • 7.1.1. Market Size Analysis and Y-o-Y Growth Analysis (%), By End-User
    • 7.1.2. Market Attractiveness Index, By End-User
  • 7.2. Hospitals*
    • 7.2.1. Introduction
    • 7.2.2. Market Size Analysis and Y-o-Y Growth Analysis (%)
  • 7.3. Specialty Clinics
  • 7.4. Home Healthcare
  • 7.5. Others

8. Advanced Wound Care Devices Market, By Regional Market Analysis and Growth Opportunities

  • 8.1. Introduction
    • 8.1.1. Market Size Analysis and Y-o-Y Growth Analysis (%), By Region
    • 8.1.2. Market Attractiveness Index, By Region
  • 8.2. North America
    • 8.2.1. Introduction
    • 8.2.2. Key Region-Specific Dynamics
    • 8.2.3. Market Size Analysis and Y-o-Y Growth Analysis (%), By Product Type
    • 8.2.4. Market Size Analysis and Y-o-Y Growth Analysis (%), By Wound Type
    • 8.2.5. Market Size Analysis and Y-o-Y Growth Analysis (%), By End-User
    • 8.2.6. Market Size Analysis and Y-o-Y Growth Analysis (%), By Country
      • 8.2.6.1. U.S.
      • 8.2.6.2. Canada
  • 8.3. Europe
    • 8.3.1. Introduction
    • 8.3.2. Key Region-Specific Dynamics
    • 8.3.3. Market Size Analysis and Y-o-Y Growth Analysis (%), By Product Type
    • 8.3.4. Market Size Analysis and Y-o-Y Growth Analysis (%), By Wound Type
    • 8.3.5. Market Size Analysis and Y-o-Y Growth Analysis (%), By End-User
    • 8.3.6. Market Size Analysis and Y-o-Y Growth Analysis (%), By Country
      • 8.3.6.1. Germany
      • 8.3.6.2. U.K.
      • 8.3.6.3. France
      • 8.3.6.4. Spain
      • 8.3.6.5. Italy
      • 8.3.6.6. Rest of Europe
  • 8.4. Latin America
    • 8.4.1. Introduction
    • 8.4.2. Key Region-Specific Dynamics
    • 8.4.3. Market Size Analysis and Y-o-Y Growth Analysis (%), By Product Type
    • 8.4.4. Market Size Analysis and Y-o-Y Growth Analysis (%), By Wound Type
    • 8.4.5. Market Size Analysis and Y-o-Y Growth Analysis (%), By End-User
    • 8.4.6. Market Size Analysis and Y-o-Y Growth Analysis (%), By Country
      • 8.4.6.1. Mexico
      • 8.4.6.2. Brazil
      • 8.4.6.3. Argentina
      • 8.4.6.4. Rest of Latin America
  • 8.5. Asia-Pacific
    • 8.5.1. Introduction
    • 8.5.2. Key Region-Specific Dynamics
    • 8.5.3. Market Size Analysis and Y-o-Y Growth Analysis (%), By Product Type
    • 8.5.4. Market Size Analysis and Y-o-Y Growth Analysis (%), By Wound Type
    • 8.5.5. Market Size Analysis and Y-o-Y Growth Analysis (%), By End-User
    • 8.5.6. Market Size Analysis and Y-o-Y Growth Analysis (%), By Country
      • 8.5.6.1. China
      • 8.5.6.2. India
      • 8.5.6.3. Japan
      • 8.5.6.4. South Korea
      • 8.5.6.5. Rest of Asia-Pacific
  • 8.6. Middle East and Africa
    • 8.6.1. Introduction
    • 8.6.2. Key Region-Specific Dynamics
    • 8.6.3. Market Size Analysis and Y-o-Y Growth Analysis (%), By Product Type
    • 8.6.4. Market Size Analysis and Y-o-Y Growth Analysis (%), By Wound Type
    • 8.6.5. Market Size Analysis and Y-o-Y Growth Analysis (%), By End-User

9. Competitive Landscape and Market Positioning

  • 9.1. Competitive Overview and Key Market Players
  • 9.2. Market Share Analysis and Positioning Matrix
  • 9.3. Strategic Partnerships, Mergers & Acquisitions
  • 9.4. Key Developments in Product Portfolios and Innovations
  • 9.5. Company Benchmarking

10. Company Profiles

  • 10.1. Smith+Nephew. *
    • 10.1.1. Company Overview
    • 10.1.2. Product Portfolio
      • 10.1.2.1. Product Description
      • 10.1.2.2. Product Key Performance Indicators (KPIs)
      • 10.1.2.3. Historic and Forecasted Product Sales
      • 10.1.2.4. Product Sales Volume
    • 10.1.3. Financial Overview
      • 10.1.3.1. Company Revenue's
      • 10.1.3.2. Geographical Revenue Shares
      • 10.1.3.3. Revenue Forecasts
    • 10.1.4. Key Developments
      • 10.1.4.1. Mergers & Acquisitions
      • 10.1.4.2. Key Product Development Activities
      • 10.1.4.3. Regulatory Approvals, etc.
    • 10.1.5. SWOT Analysis
  • 10.2. Gilero
  • 10.3. Pensar Medical
  • 10.4. Nexa Medical Limited
  • 10.5. Solventum
  • 10.6. Medela
  • 10.7. Alleva Medical Ltd.
  • 10.8. 3M
  • 10.9. Talley Group Ltd
  • 10.10. DeRoyal Industries, Inc.

LIST NOT EXHAUSTIVE

11. Assumption and Research Methodology

  • 11.1. Data Collection Methods
  • 11.2. Data Triangulation
  • 11.3. Forecasting Techniques
  • 11.4. Data Verification and Validation

12. Appendix

  • 12.1. About Us and Services
  • 12.2. Contact Us